Abstract

An economic evaluation was conducted to investigate the cost-effectiveness of ferric carboxymaltose (FCM) for the treatment of iron deficiency anemia (IDA) in Chinese adult patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call